Ritolukast
Alternative Names: WY 48252Latest Information Update: 10 Nov 1994
At a glance
- Originator Wyeth
- Class Antiasthmatics; Small molecules
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma